Bril, V, Benatar, M, Andersen, H, Vissing, J, Brock, M, Greve, B, Kiessling, P, Woltering, F, Griffin, L, Van den Bergh, P & MG0002 Investigators 2021, ' Efficacy and Safety of Rozanolixizumab in Moderate to Severe Generalized Myasthenia Gravis : A Phase 2 Randomized Control Trial ', Neurology, vol. 96, no. 6, pp. e853-e865 . https://doi.org/10.1212/WNL.0000000000011108